| Literature DB >> 16550228 |
M A A Al-Fatimi1, W-D Jülich, R Jansen, U Lindequist.
Abstract
In the course of an ethnobotanical study on fungi used in Yemeni ethnomedicine the fungus Podaxis pistillaris (Podaxales, Podaxaceae, Basidiomycetes) was found to exhibit antibacterial activity against Staphylococcus aureus, Micrococcus flavus, Bacillus subtilis, Proteus mirabilis, Serratia marcescens and Escherichia coli. In the culture medium of P. pistillaris three epidithiodiketopiperazines were identified by activity-guided isolation. Based on spectral data (NMR, ESI-MS and DCI-MS) their identity was established as epicorazine A (1), epicorazine B (2) and epicorazine C (3, antibiotic F 3822), which have not been reported as constituents of P. pistillaris previously. It is assumed that the identified compounds contribute to the antibacterial activity of the extract.Entities:
Year: 2006 PMID: 16550228 PMCID: PMC1375231 DOI: 10.1093/ecam/nek008
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Epicorazines A (1)
Antibacterial activity of the EtOAc extract from the culture medium of Podaxis pistillaris and of epicorazines in agar diffusion assay
| Strain | Zones of inhibition (mm) | |||||
|---|---|---|---|---|---|---|
| EtOAc extract | Epicorazine A | Epicorazine B | Epicorazine C | Ampicillin | Gentamicin | |
| 1 mg per disk | 100 µg per disk | 10 µg per disk | ||||
| 30 ± 3 | 35 ± 4 | 30 ± 3 | 25 ± 3 | 26 ± 2 | n.d. | |
| 20 ± 2 | 32 ± 3 | 30 ± 2 | 22 ± 2 | 31 ± 3 | n.d. | |
| 18 ± 2 | 35 ± 3 | 32 ± 3 | 20 ± 2 | 28 ± 3 | n.d. | |
| 19 ± 3 | 25 ± 2 | 24 ± 2 | 20 ± 2 | 30 ± 2 | n.d. | |
| 18 ± 1 | 20 ± 1 | 20 ± 2 | 17 ± 2 | n.d. | 15 ± 2 | |
| 18 ± 1 | 25 ± 2 | 24 ± 3 | 18 ± 3 | n.d. | 14 ± 1 | |
n.d. non detected; n = 9.
NMR-data of epicorazine A (1) in CDCl3 (1H: 300 MHz, 13C: 75 MHz)
| H | δH (p.p.m.) | m | C | δC (p.p.m.) | m | HMBC-correlated H | δC | |
|---|---|---|---|---|---|---|---|---|
| — | — | — | — | 193.69 | s | 6, 7a, 5 (3) | 194.5 | |
| 2 | 6.14 | dd | 2.4, 10.2 | 129.30 | d | 4-OH (163 Hz) | 129.5 | |
| 3 | 6.94 | dd | 1.9, 10.2 | 150.75 | s | 4-OH, 4 (165 Hz) | 151.3 | |
| 4 | 4.79 | ddt | 8.2, 1.6, 1.9 | 71.13 | d | 4-OH, 5, 6 | 71.3 | |
| 5.84 | d | 1.3 | — | — | — | |||
| 5 | 3.81 | dd | 12.8, 8.2 | 69.43 | d | 6, 7b (3) | 69.9 | |
| 6 | 3.26 | dt | 5.6, 12.8 | 48.97 | d | 7a+b (2, 5) | 49.2 | |
| 7a | 3.03 | dd | 12.8, 14.8 | 31.08 | t | — | 31.0 | |
| 7b | 2.59 | dd | 5.6, 14.8 | |||||
| — | 75.81 | d | 7a+b | 76.6 | ||||
| — | — | 164.27 | s | 7a | 165.2 |
aIn dioxane see (20), the 1H-NMR data given by Deffieux et al. were obtained in acetone-dd, where several signals overlap especially at 90 MHz. According to our spectra their assignment of the partially overlapping 2- and 2′-protons has to be exchanged;
bdirekt 1JH,C coupling.
NMR data of epicorazine B (3)
| δH | m | δ | m | HMBC-correlated H | δH | m | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | 193.70 | s | 6, 7a/b | — | — | — | ||
| 6.14 | dd | 10.3, 2.0 | 129.28 | d | — | 6.07 | dd | 10.3, 2.3 | ||
| 6.94 | dd | 10.3, 1.8 | 150.77 | d | 4-OH, 4 | 6.91 | dd | 10.3, 1.9 | ||
| 4.79 | ddt | 8.1, 1.8, 1.8c | 71.16 | d | 4-OH, 5, 6 | 4.77 | ddt | 8.5, 2.0, 2.0 | ||
| 5.88 | s | — | — | — | — | 5.22 | s | — | ||
| 3.79 | dd | 13.0, 8.1 | 69.51 | d | 7a/b, 6. 3 | 3.98 | dd | 13.1, 8.5 | ||
| 3.26 | dt | 5.7, 12.7 | 49.02 | d | 7a/b, 2 | 3.41 | dt | 5.8, 12.7 | ||
| 3.01 | dd | 15.0, 12.5 | 30.81 | t | 6 | 2.98 | dd | 14.5, 12.7 | ||
| 2.60 | dd | 15.0, 5.7 | 2.55 | dd | 14.5, 5.8 | |||||
| — | — | — | 76.19 | s | 7a/b | — | — | — | ||
| — | — | — | 164.67 | s | 7a | — | — | — | ||
| — | — | — | 193.36 | s | 6′, 7′a/b | — | — | — | ||
| 6.17 | dd | 10.4, 2.0 | 128.41 | d | — | 6.11 | dd | 10.3, 1.1 | ||
| 6.88 | dd | 10.4, 2.3 | 148.77 | d | 4′ | 6.97 | dd | 10.3, 4.1 | ||
| 4.90 | dd | 6.5, 2.4 | 67.73 | d | 5′, 2′, 6′ | 5.23 | m | — | ||
| — | — | — | — | — | — | 4.78 | d | 5.7 | ||
| 4.68 | dd | 9.7, 6.5 | 65.82 | d | 7′b, 3′, 6′ | 4.67 | dd | 7.2, 4.9 | ||
| 3.38 | ddd | 9.7, 9.7, 8.0 | 44.47 | d | 7′a/b, 2′ | 3.44 | ddd | 8.5, 7.2, 5.6 | ||
| 2.60 | dd | 8.0, 14.6 | 33.68 | t | 5′, 6′ | 2.55 | dd | 5.6, 14.4 | ||
| 3.55 | dd | 9.7, 14.6 | 3.36 | dd | 8.5, 14.4 | |||||
| — | — | — | 75.88 | s | 5′, 7′a/b | — | — | — | ||
| — | — | — | 163.76 | s | 7′a/b | — | — | — |
aIn CDCl3 (1H: 400 MHz, 13C: 100 MHz);
bin acetone-d6 (600 MHz);
cbroad;
da corresponding OH signal was not observed.
1H-NMR data of epicorazine C (3) (antibiotic F 3822)
| H | DMSO | DMSO/(D2O) | DMSO | |||||
|---|---|---|---|---|---|---|---|---|
| δ | m | δ | m | δ | ||||
| 6.07 | dd | 10, 2 | 6.06 | dd | 10.1, 2.0 | 6.05 | 10 | |
| 6.90 | dd | 10, 2 | 6.89 | dd | 9.9, 1.8 | 6.88 | 10, 2 | |
| 5.87 | s | — | — | — | — | — | — | |
| 4.68 | d | 9 br. | 4.67 | ddd | 8.5, 2.2, 2.2 | 4.67 | 8, 2 | |
| 3.98 | dd | 13, 8 | 3.94 | dd | 13.7, 9.2 | 3.96 | 13, 8 | |
| 3.34 | ddd | 13, 12, 6 | 3.34 | ddd | 12.9, 12.6, 6.0 | 3.33 | 13, 12, 6 | |
| 2.53 | m | — | 2.54 | m | — | 2.55 | 17, 5 | |
| 2.84 | dd | 14, 12 | 2.84 | dd | 14.2, 12.7 | 2.86 | 14, 12 | |
| 2.70 | dd | 16, 10 | 2.70 | dd | 16.3, 10.2 | 2.69 | 17, 10 | |
| 2.53 | m | — | 2.54 | m | — | 2.51 | 14, 6 | |
| 3.71 | ddd | 10, 5, 5, 2 | 3.71 | ddd | 10.4, 4.3, 1.8 | 3.76 | 10, 5, 2 | |
| 5.14 | d | 5 | — | — | — | — | — | |
| 4.78 | ddd | 5, 5, 2, 1 br | 4.77 | d | 4.6 br | 4.73 | 5, 2 | |
| 5.46 | d | 5 | — | — | — | — | — | |
| 4.40 | dd | 7, 5 | 4.41 | dd | 7.1, 4.6 | 4.43 | 8, 5 | |
| 3.17 | dddd | 8, 7, 2, 2 | 3.18 | ddd | 7.8, 7.5, 2.4 | 3.18 | 8, 3 | |
| 2.99 | dd | 15, 8 | 2.99 | dd | 14.2, 8.1 | 3.02 | 15, 8, 2 | |
| 2.79 | dd | 15, 2 | 2.79 | dd | 14.5, 2.3 | 2.79 | 15, 3 | |
a600 MHz;
b400 MHz;
cJapan. Pat. 91-227 991;
doverlap of 2′b- and 7b-H.